Literature DB >> 7231153

Infections due to Lancefield group F and related Streptococci (S. milleri, S. anginosus).

D M Shlaes, P I Lerner, E Wolinsky, K V Gopalakrishna.   

Abstract

We can no longer accept classification of streptococci solely on the basis of hemolytic reactions or Lancefield agglutinations. While the "viridans" streptococci cannot be serologically differentiated, physiological separation of the species offers a satisfactory method of classifying human isolates. We review the microbiology of Lancefield group F and related streptococci (S. milleri, S. anginosus), emphasizing microbial ecology and current taxonomic considerations. A series of 28 patients infected with these organisms is presented. There was a striking male predominance in the series (6:1) as well as an obvious association with underlying diseases and/or antecedent trauma. The most remarkable feature of these pathogens is their predilection for abscess formation, confirming their overdue recognition as the most common "viridans" streptococcus recovered from abscesses within internal organs. We observed purulent disease of the nervous and skeletal systems, oral cavity, lung and pleural space, abdomen and subcutaneous tissues. Microbial synergy (i.e. polymicrobic infection) was not a requisite for abscess formation. Four of the five deaths in this series occurred in patients 60 years of age of older. Some degree of variability in antimicrobial susceptibility was noted, so speciation alone may not always provide sufficient information on which to base a therapeutic decision.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7231153     DOI: 10.1097/00005792-198105000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  30 in total

Review 1.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Splenic abscess and multiple brain abscesses caused by Streptococcus intermedius in a young healthy man.

Authors:  Jepsin Maliyil; William Caire; Rajasree Nair; Debbie Bridges
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-07

3.  Septic Streptococcus milleri prepatellar bursitis.

Authors:  E Meys; L Michaux; M Lambert; R Triki; C Nagant de Deuxchaisnes
Journal:  Clin Rheumatol       Date:  1992-03       Impact factor: 2.980

4.  Fatal infection in neonates of 26 weeks' gestation due to Streptococcus milleri: report of two cases.

Authors:  R A Cox; K Chen; A L Coykendall; P Wesbecher; V C Herson
Journal:  J Clin Pathol       Date:  1987-02       Impact factor: 3.411

5.  Streptococcus milleri subcutaneous abscesses in drug addicts.

Authors:  F Müller; A von Graevenitz; T Ferber
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

6.  Presumptive identification of "Streptococcus milleri" in 5 h.

Authors:  K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

7.  Comparison of latex agglutination and immunofluorescence for direct Lancefield grouping of streptococci from blood cultures.

Authors:  D M Shlaes; Z Toossi; A Patel
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

8.  Clinical significance of Streptococcus milleri.

Authors:  P Van der Auwera
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

9.  Mycotic Aneurysm Caused by Streptococcus constellatus subsp. constellatus.

Authors:  Wen-Chu Chiang; Jui-Chang Tsai; Shey-Ying Chen; Chiung-Yuan Hsu; Chen-Tu Wu; Lee-Jene Teng; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 10.  Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature.

Authors:  MaryAnn P Tran; Molly Caldwell-McMillan; Walid Khalife; Vincent B Young
Journal:  BMC Infect Dis       Date:  2008-11-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.